Back to Search Start Over

The role of REV-ERB in NASH

Authors :
Griffett, Kristine
Hayes, Matthew E.
Boeckman, Michael P.
Burris, Thomas P.
Source :
Acta Pharmacol Sin
Publication Year :
2022
Publisher :
Springer Science and Business Media LLC, 2022.

Abstract

REV-ERBs are atypical nuclear receptors as they function as ligand-regulated transcriptional repressors. The natural ligand for the REV-ERBs (REV-ERBĪ± and REV-ERBĪ²) is heme, and heme-binding results in recruitment of transcriptional corepressor proteins such as N-CoR that mediates repression of REV-ERB target genes. These two receptors regulate a large range of physiological processes including several important in the pathophysiology of non-alcoholic steatohepatitis (NASH). These include carbohydrate and lipid metabolism as well as inflammatory pathways. A number of synthetic REV-ERB agonists have been developed as chemical tools and they show efficacy in animal models of NASH. Here, we will review the functions of REV-ERB with regard to their relevance to NASH as well as the potential to target REV-ERB for treatment of this disease.

Details

ISSN :
17457254 and 16714083
Volume :
43
Database :
OpenAIRE
Journal :
Acta Pharmacologica Sinica
Accession number :
edsair.doi.dedup.....06accb5cf71fa86df9b533a58297e22f
Full Text :
https://doi.org/10.1038/s41401-022-00883-w